The Jindal Supreme (India) IPO is a closed mainboard Bookbuilding offer (Fresh capital cum OFS) that opened on 16 September 2026. The Jindal Supreme (India) IPO closed on 18 September 2026, with an issue price of ₹93 per share. The Jindal Supreme (India) IPO has a face value of ₹10 and a lot size of 161 shares. The Jindal Supreme (India) IPO size aggregates up to ₹125 crore, listing on NSE & BSE on 23 September 2026. The Jindal Supreme (India) IPO allotment was scheduled for 21 September 2026.
On the financial front, the Jindal Supreme (India) IPO reported revenue of ₹191 crore for 30 Jun 2026, compared with ₹676 crore for 31 Mar 2026. The Jindal Supreme (India) IPO PAT was ₹8 crore against ₹23 crore. The Jindal Supreme (India) IPO EBITDA stood at ₹14 crore with a 7.20% margin. The Jindal Supreme (India) IPO net worth as of 30 Jun 2026 was ₹105 crore.
Always verify The Jindal Supreme (India) IPO details and GMP data with the official offer document before investing in the Jindal Supreme (India) IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Jun 2026
31 Mar 2026
31 Mar 2025
Total Assets
233
248
200
Revenue
191
676
605
PAT
8
23
24
EBITDA
14
42
26
Net Worth
105
97
75
Reserves
65
56
72
Total Borrowing
92
120
96
Jindal Supreme (India) IPO Financials FAQs
Revenue of Jindal Supreme (India) (Amount in ₹ Crore) — 30 Jun 2026: 191; 31 Mar 2026: 676; 31 Mar 2025: 605. Profit after tax (PAT) — 30 Jun 2026: 8; 31 Mar 2026: 23; 31 Mar 2025: 24.
EBITDA of Jindal Supreme (India) (Amount in ₹ Crore) — 30 Jun 2026: 14; 31 Mar 2026: 42; 31 Mar 2025: 26. The EBITDA margin is 7.20%.
Total assets — 30 Jun 2026: 233; 31 Mar 2026: 248; 31 Mar 2025: 200. Net worth — 30 Jun 2026: 105; 31 Mar 2026: 97; 31 Mar 2025: 75. Reserves & surplus — 30 Jun 2026: 65; 31 Mar 2026: 56; 31 Mar 2025: 72. (Amount in ₹ Crore)
Total borrowing of Jindal Supreme (India) (Amount in ₹ Crore) — 30 Jun 2026: 92; 31 Mar 2026: 120; 31 Mar 2025: 96. Debt-to-equity ratio: 0.88.
The financials shown for Jindal Supreme (India) IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
